Healthtech Startups

Genobank provides a platform for patients to own, control, and monetize their genomic data through blockchain-linked biosamples and AI-powered bioinformatics workflows. The platform enables patients to share their biological data with researchers and clinical trials while maintaining transparency and earning potential from data licensing.

2 investors

LifeView, operated by Genomic Prediction, offers preimplantation genetic testing (PGT) for IVF embryos, including screening for aneuploidy, monogenic disorders, structural rearrangements, and polygenic disease risk. Its tests serve fertility clinics and IVF patients to help select embryos for transfer.

2 investors

Genomics builds a genotype-phenotype database and genetic risk-prediction tools used to support pharmaceutical drug discovery and clinical trials, as well as population health management and clinical decision support for healthcare providers. It serves life sciences companies and healthcare systems through its Life Sciences and Health & Wellness divisions.

2 investors

Genvax Technologies develops mRNA and nanoparticle-based vaccines for livestock, focusing on custom, herd-specific formulations that aim to improve speed and precision compared to conventional vaccine platforms. The company serves animal health and food supply sectors.

2 investors

GeroCare is a home medical service company providing healthcare access to underserved populations across Africa. It leverages technology to deliver medical care to people in remote and underserved segments.

2 investors

Geron is a biopharmaceutical company focused on developing therapies for blood cancer. The company has over 30 years of experience in research and clinical development.

2 investors

Gerostate Alpha creates drug candidates targeting age-related conditions and long-term illnesses.

2 investors

Gestalt provides a vendor-neutral digital pathology platform and professional services that enable pathology laboratories and health systems to modernize workflows, integrate AI tools, and manage diagnostic imaging without vendor lock-in. The company serves enterprise hospitals, academic medical centers, and pathology groups seeking interoperable solutions across scanners, laboratory information systems, and AI applications.

2 investors

Gesund develops an AI platform for clinical decision support and medical data analysis. The company serves healthcare providers and clinical researchers.

2 investors

Giftshed builds a single-cell cancer data platform that images billions of cells from whole blood, uses Vision AI and robotics to detect and isolate rare circulating tumor cells, and applies single-cell RNA sequencing and multi-omics to guide precision cancer therapy. The platform is aimed at personalized cancer diagnostics and metastatic biology research.

2 investors

Gila Therapeutics is a clinical-stage biotech company developing a topical lingual signaling platform that delivers micro-dose PYY dissolving on the tongue to activate brain regions regulating food intake and metabolism. Its treatments target obesity, type 2 diabetes, and associated cardiometabolic disorders.

2 investors

Gisens Biotech develops G-LoC, a portable graphene-based biochip technology that delivers rapid health monitoring and diagnostic test results from home samples in minutes rather than days. The company's initial product, KF4+, is designed for patients with chronic kidney disease to perform comprehensive kidney function testing at home with results integrated into electronic health records.

2 investors

Gleam is an AI-assisted data entry tool designed for clinical research sites to move data from source systems into electronic data capture systems faster and with higher accuracy. The product helps clinical research coordinators reduce manual transcription work while maintaining full traceability and coordinator control over data entries.

2 investors

Global Vascular develops medical devices based on its BioDiamond Technology, including antithrombotic diamond (F-DLC) coatings, drug-eluting stents, and catheters for vascular and interventional treatments. The company emerged from a medical-engineering research collaboration between Keio University and Tokai University in Japan.

2 investors

GlycoMimetics is a company developing cancer therapies, aiming to advance treatment options for people living with cancer. It operates in the oncology-focused biotech field.

2 investors

GoMo Health provides digital healthcare engagement solutions that guide patients and members toward meaningful health actions through evidence-based content, care pathways, and human-centered design. The company serves health plans, provider organizations, and employers with condition-specific and life-stage-specific engagement programs covering pediatrics, behavioral health, chronic disease management, and preventive care.

2 investors

Good Life Sorted provides in-home support services connecting older adults with trained helpers for companionship and assistance with daily chores. The company operates across southern England, matching customers with reliable neighbors to enable independent living at home.

2 investors

GoodMaps builds AI-driven indoor navigation technology to help people, including those with visual impairments, orient and move through indoor spaces. The product is offered to venues seeking to make their indoor environments more accessible and inclusive.

2 investors

GoTu connects qualified dental professionals with dental offices that need temporary staffing support. The platform serves the dental industry by addressing staffing shortages through verified professional placements.

2 investors

Granata Bio is a US-based biopharmaceutical company focused on reproductive health and fertility, in-licensing IVF medications used outside the US to develop and commercialize them in North America. Its aim is to expand therapeutic options, lower costs, and increase access to fertility treatment for patients.

2 investors

Grand River Aseptic Manufacturing (GRAM) is a contract development and manufacturing organization (CDMO) specializing in sterile fill-finish and aseptic manufacturing of injectable pharmaceutical and biologic products. It serves pharmaceutical and biotech clients across the drug product lifecycle, from development through commercial supply.

2 investors

Grannus Therapeutics develops Hsp90 inhibitors that selectively target the beta isoform of the Hsp90 protein for cancer treatment. Its lead candidate, GRE317, is designed for single-agent anti-tumor activity and combination with therapies such as PARP inhibitors and immunotherapies, with programs advancing toward IND-enabling milestones and clinical studies.

2 investors

Grape offers a sickness allowance insurance product integrated with a platform that connects HR, payroll, and time tracking systems to manage employee absences, process claims, and identify trends. The platform serves companies seeking to protect labor costs and simplify absence management from day one.

2 investors

Gray Matter Analytics provides healthcare data analytics for value-based contract management and performance monitoring, serving state Medicaid agencies, payors, and providers. Its platform uses AI/machine learning to identify care gaps, forecast contract outcomes, reduce costs, and improve health equity across commercial and government contracts.

2 investors